Severe hyponatremia, hyperglycemia, and hyperlactatemia are associated with intraoperative hyperthermic intraperitoneal chemoperfusion with oxaliplatin

Peritoneal Dialysis International

Volumn 28, Issue 1, 2008, Pages 61-66

  de Somer, Filip ^a   Ceelen, Wim ^a   Delanghe, Joris ^a   de Smet, Dirk ^a   Vanackere, Martin ^a   Pattyn, Piet ^a   Mortier, Eric ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Hyperthermic intraperitoneal chemoperfusion; Metabolic disorder; Oxaliplatin

Indexed keywords

GLUCOSE; OXALIPLATIN; POTASSIUM ION; SODIUM ION; ANTINEOPLASTIC AGENT; PLATINUM COMPLEX; SODIUM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DIALYSATE; DISEASE SEVERITY; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERLACTATEMIA; HYPONATREMIA; ION EXCHANGE; MALE; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; PERITONEUM CANCER; POTASSIUM TRANSPORT; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; SODIUM TRANSPORT; SURGICAL TECHNIQUE; TOTAL BODY WATER; ABDOMINAL TUMOR; ADJUVANT CHEMOTHERAPY; BIOLOGICAL MODEL; ELECTROLYTE BALANCE; GLUCOSE BLOOD LEVEL; HYPERTHERMIC THERAPY; INFUSION; LACTIC ACIDOSIS; METABOLISM; METHODOLOGY; MIDDLE AGED; PEROPERATIVE CARE; REGIONAL PERFUSION; RETROSPECTIVE STUDY;

ABDOMINAL NEOPLASMS; ACIDOSIS, LACTIC; ADULT; AGED; ANTINEOPLASTIC AGENTS; BLOOD GLUCOSE; CHEMOTHERAPY, ADJUVANT; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; FEMALE; HUMANS; HYPERGLYCEMIA; HYPERTHERMIA, INDUCED; HYPONATREMIA; INFUSIONS, PARENTERAL; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; ORGANOPLATINUM COMPOUNDS; RETROSPECTIVE STUDIES; SODIUM; WATER-ELECTROLYTE BALANCE;

EID: 42449142042     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080802800111     Document Type: Article

References (12)

1. Witkamp AJ, de Bree E, Van Goethem R, Zoetmulder FA. Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy. Cancer Treat Rev 2001; 27:365-74.
2. Ceelen WP, Hesse U, de Hemptinne B, Pattyn P. Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer. Br J Surg 2000; 87:1006-15.
3. Curis E, Provost K, Bouvet D, Nicolis I, Crauste-Manciet S, Brossard D, et al. Carboplatin and oxaliplatin decomposition in chloride medium, monitored by XAS. J Synchrotron Radiat 2001; 8:716-18.
4. Jerremalm E, Hedeland M, Wallin I, Bondesson U, Ehrsson H. Oxaliplatin degradation in the presence of chloride: identification and cytotoxicity of the monochloro monooxalato complex. Pharm Res 2004; 21:891-4.
5. Hillier TA, Abbott RD, Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia. Am J Med 1999; 106:399-403.
6. Nguyen MK, Kurtz I. Are the total exchangeable sodium, total exchangeable potassium and total body water the only determinants of the plasma water sodium concentration? Nephrol Dial Transplant 2003; 18:1266-71.
7. Nguyen MK, Kurtz I. A new formula for predicting alterations in plasma sodium concentration in peritoneal dialysis. Am J Physiol Renal Physiol 2005; 288:F1113-F1117.
8. Seldin DW. Glucose in the development and treatment of diabetic acidosis. Tex State J Med 1953; 49:738-43.
9. Seldin DW, Tarail R. The metabolism of glucose and electrolytes in diabetic acidosis. J Clin Invest 1950; 29:552-65.
10. Burr RG. Determination of urinary sodium and potassium by ion-selective electrodes and flame photometry compared. Clin Chem 1982; 28:1710-11.
11. Burkart JM, Nolph KD. Peritoneal dialysis. In: Brenner BM, ed. The Kidney. 5th ed. Philadelphia: W.B. Saunders; 1996: 2507-75.
12. Revelly JP, Tappy L, Martinez A, Bollmann M, Cayeux MC, Berger MM, et al. Lactate and glucose metabolism in severe sepsis and cardiogenic shock. Crit Care Med 2005; 33: 2235-40.